Benzenesulfonamide,4-amino-N-(4-methyl-2-pyrimidinyl)-, sodium salt (1:1) cas no:127-58-2
Synonyms: Benzenesulfonamide,4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodium salt (9CI);Sodium,[N1-(4-methyl-2-pyrimidinyl)sulfanilamido]- (7CI);Sulfamerazine, sodium deriv.(6CI);Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, monosodium salt (8CI);2-Sulfanilamido-4-methylpyrimidine sodium salt;4-Methyl-2-sulfanilamidopyrimidine sodium salt;Monosodium2-sulfanilamido-4-methylpyrimidine;Sodium sulfamerazine;Solublesulfamerazine;Solumedine;
NameBenzenesulfonamide,4-amino-N-(4-methyl-2-pyrimidinyl)-, sodium salt (1:1)
CAS127-58-2
SynonymsBenzenesulfonamide,4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodium salt (9CI);Sodium,[N1-(4-methyl-2-pyrimidinyl)sulfanilamido]- (7CI);Sulfamerazine, sodium deriv.(6CI);Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, monosodium salt (8CI);2-Sulfanilamido-4-methylpyrimidine sodium salt;4-Methyl-2-sulfanilamidopyrimidine sodium salt;Monosodium2-sulfanilamido-4-methylpyrimidine;Sodium sulfamerazine;Solublesulfamerazine;Solumedine;
EINECS(EC#)204-851-0
Molecular FormulaC11H11N4NaO2S
Molecular Weight286.28
Hazard Xn: Harmful;
Risk R20/22
Safety
Hazard Codes: Xn,Xi .gif)
Risk Statements : 20/22-36/37/38
20/22: Sodium sulfamerazine of (127-58-2) is harmful by inhalation and if swallowed
36/37/38: Irritating to eyes, respiratory system and skin
Safety Statements : 7-24-45-36-26
7: Keep container tightly closed
24: Avoid contact with skin
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
WGK Germany: 3
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| mouse |
LD50 |
intraperitoneal |
1522mg/kg (1522mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 17, 1944. |
| mouse |
LD50 |
intravenous |
900mg/kg (900mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 94, Pg. 338, 1953. |
| mouse |
LD50 |
oral |
2800mg/kg (2800mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 94, Pg. 338, 1953. |
| mouse |
LD50 |
subcutaneous |
1739mg/kg (1739mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 17, 1944. |
